{
  "docId": "019de073-d0ca-7288-9ab4-c51009336f37",
  "docSlug": "2ef2fad38453444b0a07cd5e908bf527",
  "documentTitle": "PaxMedica | Investor Presentation Deck | 24 slides",
  "authorId": "paxmedica",
  "authorName": "PaxMedica",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 9,
  "pageCount": 24,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Focuses on the regulatory milestone of an NDA filing and the associated Priority Review Voucher (PRV) opportunity.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-d0ca-7288-9ab4-c51009336f37/9",
  "deckHref": "/decks/019de073-d0ca-7288-9ab4-c51009336f37",
  "deckJsonHref": "/decks/019de073-d0ca-7288-9ab4-c51009336f37.json",
  "deckAnchorHref": "/decks/019de073-d0ca-7288-9ab4-c51009336f37#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.02,
        "y": 0.96
      },
      "kind": "disclaimer",
      "text": "© 2022. PaxMedica, Inc. Proprietary Information. All rights reserved",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e784e7d6-dc44-44d1-aa87-bb4a2091af5f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.15,
        "x": 0.84,
        "y": 0.02
      },
      "kind": "image",
      "text": "PAXMEDICA",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57ccdb3e-c64b-4546-812e-a3ebfc44bd4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "Primary efficacy data expected from a retrospective data analysis of patients treated with suramin for HAT compared to a natural history cohort from a prior HAT epidemic before availability of suramin treatment. PaxMedica has exclusive license to the only treatment records for hundreds of TbR HAT patients treated with suramin (2000-2020) in certain hospitals in Uganda and Malawi, the epicenter of recorded infections. FDA feedback from two documented meetings confirm specific requirements for the NDA and PRV filing process. Filing NDA anticipated in late 2023. Accelerated review/approval expected and, if approved, subsequent PRV award and potential sale.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "147f7736-e257-48db-b24d-48472ff581c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "title",
      "text": "Plan for Potential Approval and Receipt of Transactable Voucher:",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3002c2fd-cbf0-4fc6-be2d-cc80f185a9b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Anticipated Near-term Milestone: Complete NDA for HAT",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f70fba7f-d2b5-4ef4-b36d-9e7b7817f445",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}